Manufacturing
Flexible single-use manufacturing technologies at an advanced global site
Our facility employs state-of-the-art single use mammalian cell culture technologies in upstream and downstream process development mirrored in design with our cGMP manufacturing for consistent and robust tech transfer and scale-up. From cell line development through cGMP production along with associated analytical development and validation, Bora delivers high-yield, high-quality processes for our client programs – even with the most challenging molecules.
Take a look at our biologics site in Zhubei, Taiwan.
Cell Engineering – Developing protein therapeutics is difficult because they are highly complex molecules that are grown by living cells cultured and cultivated in a precise, reproducible fashion. At Bora Biologics, we have mastered the art and science of cell engineering, cell culture, and protein purification.
Key Features
-
- Segregated USP/DSP
- 2 x 500L bioreactors
- Gowning facilities
- Separated post viral processing
- Clean utility systems (WFI/CS/CA)
- HVAC systems and controls
Platform – As a top CDMO, we have a platform approach to developing biologics that allows us to perform all activities needed to transform biologics from concept to clinical product in-house.
Facility capabilities
-
- Segregated upstream and downstream processing areas
- Segregated media buffer preparation and holding areas
- A two-suite purification area for pre-/post-viral processing and bulk filling
Robust biologics capabilities, designed to accommodate biopharma’s unique needs
Our solutions for biologics include cell-line and process development, analytics and formulations development, as well as full cGMP manufacturing and drug product filling and finishing services.